|
| 36255625 | Synthesis, Biochemical, and Cellular Evaluation of HDAC6 Targeting Proteolysis Targeting Chimeras. | Methods Mol Biol | 2023 |
| 37902787 | Development of First-in-Class Dual Sirt2/HDAC6 Inhibitors as Molecular Tools for Dual Inhibition of Tubulin Deacetylation. | J Med Chem | 2023 |
| 36853683 | In cellulo and in vivo assays for compound testing against Trypanosoma cruzi. | STAR Protoc | 2023 |
| 36250286 | Chemically Diverse S. mansoni HDAC8 Inhibitors Reduce Viability in Worm Larval and Adult Stages. | ChemMedChem | 2023 |
| 35306288 | Identification of histone deacetylase 10 (HDAC10) inhibitors that modulate autophagy in transformed cells. | Eur J Med Chem | 2022 |
| 35608330 | First Fluorescent Acetylspermidine Deacetylation Assay for HDAC10 Identifies Selective Inhibitors with Cellular Target Engagement. | Chembiochem | 2022 |
| 35496799 | Efficient CRISPR-Cas9-mediated genome editing for characterization of essential genes in <i>Trypanosoma cruzi</i>. | STAR Protoc | 2022 |
| 36449385 | Development of Alkylated Hydrazides as Highly Potent and Selective Class I Histone Deacetylase Inhibitors with T cell Modulatory Properties. | J Med Chem | 2022 |
| 35983937 | Phenotypic Screening of Histone Deacetylase (HDAC) Inhibitors against Schistosoma mansoni. | ChemMedChem | 2022 |
| 35886887 | Design, Synthesis and Biological Characterization of Histone Deacetylase 8 (HDAC8) Proteolysis Targeting Chimeras (PROTACs) with Anti-Neuroblastoma Activity. | Int J Mol Sci | 2022 |
| 34057470 | The structure of the mouse ADAT2/ADAT3 complex reveals the molecular basis for mammalian tRNA wobble adenosine-to-inosine deamination. | Nucleic Acids Res | 2021 |
| 33741961 | Citrullination of pyruvate kinase M2 by PADI1 and PADI3 regulates glycolysis and cancer cell proliferation. | Nat Commun | 2021 |
| 33925246 | Binding Free Energy (BFE) Calculations and Quantitative Structure-Activity Relationship (QSAR) Analysis of <i>Schistosoma mansoni</i> Histone Deacetylase 8 (<i>sm</i>HDAC8) Inhibitors. | Molecules | 2021 |
| 35008795 | Synthesis, Molecular Docking and Biological Characterization of Pyrazine Linked 2-Aminobenzamides as New Class I Selective Histone Deacetylase (HDAC) Inhibitors with Anti-Leukemic Activity. | Int J Mol Sci | 2021 |
| 34936867 | Species-selective targeting of pathogens revealed by the atypical structure and active site of Trypanosoma cruzi histone deacetylase DAC2. | Cell Rep | 2021 |
| 34392190 | Synthesis, structure-activity relationships, cocrystallization and cellular characterization of novel smHDAC8 inhibitors for the treatment of schistosomiasis. | Eur J Med Chem | 2021 |
| 32497960 | Design, synthesis, and biological evaluation of dual targeting inhibitors of histone deacetylase 6/8 and bromodomain BRPF1. | Eur J Med Chem | 2020 |
| 31816172 | Structure-Based Design, Synthesis, and Biological Evaluation of Triazole-Based smHDAC8 Inhibitors. | ChemMedChem | 2020 |
| 33357372 | La Société de Biologie de Strasbourg⿿: 100 ans au service de la science et de la société. | Biol Aujourdhui | 2020 |
| 30645113 | Synthesis and Biological Investigation of Phenothiazine-Based Benzhydroxamic Acids as Selective Histone Deacetylase 6 Inhibitors. | J Med Chem | 2019 |
| 31682411 | One-Atom Substitution Enables Direct and Continuous Monitoring of Histone Deacylase Activity. | Biochemistry | 2019 |
| 31496251 | Structure-Reactivity Relationships on Substrates and Inhibitors of the Lysine Deacylase Sirtuin 2 from <i>Schistosoma mansoni</i> (<i>Sm</i>Sirt2). | J Med Chem | 2019 |
| 29685969 | Isoform-selective HDAC1/6/8 inhibitors with an imidazo-ketopiperazine cap containing stereochemical diversity. | Philos Trans R Soc Lond B Biol Sci | 2018 |
| 29806110 | Synthesis, Crystallization Studies, and in vitro Characterization of Cinnamic Acid Derivatives as SmHDAC8 Inhibitors for the Treatment of Schistosomiasis. | ChemMedChem | 2018 |
| 30092367 | Novel spiroindoline HDAC inhibitors: Synthesis, molecular modelling and biological studies. | Eur J Med Chem | 2018 |
| 30347148 | Characterization of Histone Deacetylase 8 (HDAC8) Selective Inhibition Reveals Specific Active Site Structural and Functional Determinants. | J Med Chem | 2018 |
| 29498707 | A Novel Class of Schistosoma mansoni Histone Deacetylase 8 (HDAC8) Inhibitors Identified by Structure-Based Virtual Screening and In Vitro Testing. | Molecules | 2018 |
| 28574690 | Design, Multicomponent Synthesis, and Anticancer Activity of a Focused Histone Deacetylase (HDAC) Inhibitor Library with Peptoid-Based Cap Groups. | J Med Chem | 2017 |
| 28406899 | Histone deacetylase inhibition modulates histone acetylation at gene promoter regions and affects genome-wide gene transcription in Schistosoma mansoni. | PLoS Negl Trop Dis | 2017 |
| 29190092 | Structure-Based Design and Biological Characterization of Selective Histone Deacetylase 8 (HDAC8) Inhibitors with Anti-Neuroblastoma Activity. | J Med Chem | 2017 |
| 28537315 | Photochromic histone deacetylase inhibitors based on dithienylethenes and fulgimides. | Org Biomol Chem | 2017 |
| 28639720 | Isophthalic Acid-Based HDAC Inhibitors as Potent Inhibitors of HDAC8 from Schistosoma mansoni. | Arch Pharm (Weinheim) | 2017 |
| 28581289 | Alkoxyurea-Based Histone Deacetylase Inhibitors Increase Cisplatin Potency in Chemoresistant Cancer Cell Lines. | J Med Chem | 2017 |
| 28682233 | [History of the Strasbourg Society of Biology]. | Biol Aujourdhui | 2017 |
| 26974126 | Molecular basis and specificity of H2A.Z-H2B recognition and deposition by the histone chaperone YL1. | Nat Struct Mol Biol | 2016 |
| 28327287 | Combattre les maladies négligées en ciblant sélectivement leurs enzymes épigénétiques : le cas de la désacétylase 8 (HDAC8) de Schistosoma mansoni. | Biol Aujourdhui | 2016 |
| 26653328 | Synthesis and Biological Investigation of Oxazole Hydroxamates as Highly Selective Histone Deacetylase 6 (HDAC6) Inhibitors. | J Med Chem | 2016 |
| 27165318 | Complex Reconstitution and Characterization by Combining Co-expression Techniques in Escherichia coli with High-Throughput. | Adv Exp Med Biol | 2016 |
| 27246211 | Large-Scale Overproduction and Purification of Recombinant Histone Deacetylase 8 (HDAC8) from the Human-Pathogenic Flatworm Schistosoma mansoni. | Methods Mol Biol | 2016 |
| 26937828 | Structure-Based Design and Synthesis of Novel Inhibitors Targeting HDAC8 from Schistosoma mansoni for the Treatment of Schistosomiasis. | J Med Chem | 2016 |
| 25325257 | Fluorescence-based screening assays for the NADâº-dependent histone deacetylase smSirt2 from Schistosoma mansoni. | J Biomol Screen | 2015 |
| 26595183 | Homology modeling of parasite histone deacetylases to guide the structure-based design of selective inhibitors. | J Mol Graph Model | 2015 |
| 26013035 | HDAC8: a multifaceted target for therapeutic interventions. | Trends Pharmacol Sci | 2015 |
| 25996070 | Drugging the schistosome zinc-dependent HDACs: current progress and future perspectives. | Future Med Chem | 2015 |
| 25996069 | Schistosome sirtuins as drug targets. | Future Med Chem | 2015 |
| 25502194 | Characterization and production of protein complexes by co-expression in Escherichia coli. | Methods Mol Biol | 2015 |
| 24234454 | Characterization of the interaction between protein Snu13p/15.5K and the Rsa1p/NUFIP factor and demonstration of its functional importance for snoRNP assembly. | Nucleic Acids Res | 2014 |
| 25462986 | Hydroxamates of para-aminobenzoic acid as selective inhibitors of HDAC8. | Bioorg Chem | 2014 |
| 25209997 | TAF4, a subunit of transcription factor II D, directs promoter occupancy of nuclear receptor HNF4A during post-natal hepatocyte differentiation. | Elife | 2014 |
| 25243797 | Discovery of inhibitors of Schistosoma mansoni HDAC8 by combining homology modeling, virtual screening, and in vitro validation. | J Chem Inf Model | 2014 |